Effects of Asenapine and Paliperidone on Depression, Anxiety and Analgesy in Mice: Alterations in Brain Neurotrophic Factors, Neurogenesis, and Blood Enzyme Levels

10.4077/CJP.2018.BAH626

Esen Gumuslu；Oguz Mutlu；Sibel Kokturk；Guner Ulak；Fatma Ceyla Eraldemir；Ozan Can Tatar；Alisan Burak Yasar；Pelin Tanyeri；Furuzan Akar；Faruk Erden

antipsychotics ； behaviour ； neurodegeneration ； neurotrophic factors

The Chinese Journal of Physiology

61卷5期（2018 / 10 / 31）

280 - 292

英文

Schizophrenia, an important brain neurodevelopmental disorder, is observed in 1% of the global population. New-generation antipsychotics have been developed as alternatives to typical antipsychotics for more effective and safe therapy. Chronic administration of asenapine and paliperidone compared to haloperidol on depression, anxiety and analgesy in the forced swimming test (FST), elevated plus maze (EPM) and hot plate tests were examined in mice. Moreover effects of drugs, on expression levels of brain neurotrophic factors [brain-derived neurotrophic factor (BDNF), cAMP response element binding protein (CREB),nerve growth factor (NGF), synapsin and fibroblast growth factor 2 (FGF2)] in the hippocampus of mice, neurogenesis and neurodegeneration, and blood enzyme levels were also investigated. In FST, haloperidol (0.25 mg/kg) significantly increased immobility time while both asenapine (0.075 mg/kg) and paliperidone (0.25 and 0.50 mg/kg) significantly diminished this parameter. In EPM test, haloperidol significantly increased both % time spent in open arms and % open arm entries. Asenapine (0.075 mg/kg) and paliperidone (0.50 mg/kg) significantly increased % time spent in the open arms. They also increased % open arm entries, but this parameter failed to reach a statistically significant value. In hot plate test, haloperidol (0.125 and 0.25 mg/kg) and paliperidone (0.25 and 0.50 mg/kg) significantly increased the latency to lick the hind paws but asenapine had no effect. Asenapine and paliperidone upregulated more neurotrophic factors in the brain and caused less neurodegeneration compared to haloperidol. Investigated drugs had no effect on liver enzymes and plasma glucose levels. Asenapine and paliperidone may be preferred over classical antipsychotics since they have antidepressant-like effect, upregulate more neurotrophic factors and cause less neurodegeneration in naive mice without having diabetogenic and liver damaging effects. Paliperidone seems to possess superior effects compared to asenapine since it also exerts analgesic-like effect.

1. Alfonso, J.,Frasch, A.C.,Flugge, G.(2005).Chronic stress, depression and antidepressants: effects on gene transcription in the hippocampus.Rev. Neurosci.,16,43-56.
2. Alphs, L.,Fu, D.J.,Turkoz, I.(2016).Paliperidone for the treatment of schizoaffective disorder.Expert. Opin. Pharmacother.,17,871-883.
3. Aydemir, C.,Yalcin, E.S.,Aksaray, S.,Kisa, C.,Yildirim, S.G.,Uzbay, T.,Goka, E.(2006).Brain-derived neurotrophic factor (BDNF) changes in the serum of depressed women.Prog. Neuropsychopharmacol. Biol. Psychiatry,30,1256-1260.
4. Bourin, M.,Dailly, E.,Hascöet, M.(2004).Preclinical and clinical pharmacology of cyamemazine: anxiolytic effects and prevention of alcohol and benzodiazepine withdrawal syndrome.CNS Drug Rev.,10,219-229.
5. Branchi, I.,Francia, N.,Alleva, E.(2004).Epigenetic control of neurobehavioural plasticity: The role of neurotrophins.Behav. Pharmacol.,15,353-362.
6. Calabrese, F.,Molteni, R.,Racagni, G.,Riva, M.A.(2009).Neuronal plasticity: a link between stress and mood disorders.Psychoneuroendocrinology,34,208-216.
7. Cao, B.J.,Rodgers, R.J.(1997).Dopamine D4 receptor and anxiety: behavioural profiles of clozapine, L-745,870 and L-741,742 in the mouse plus-maze.Eur. J. Pharmacol.,335,117-125.
8. Chichenkov, O.N.,Korobov, N.V.,Petrov, V.E.(1985).Effect of haloperidol on the analgesic activity of opiate agonists administered intracisternally and intrathecally.Farmakol. Toksikol.,48,58-61.
9. Chintoh, A.F.,Mann, S.W.,Lam, L.,Giacca, A.,Fletcher, P.,Nobrega, J.,Remington, G.(2009).Insulin resistance and secretion in vivo: effects of different antipsychotics in an animal model.Schizophr. Res.,108,127-133.
10. Duman, E.,Kesim, M.,Kadioglu, M.,Ulku, C.,Kalyoncu, N.,Yaris, E.(2006).Effect of gender on antinociceptive effect of paroxetine in hot plate test in mice.Prog. Neuropsychopharmacol. Biol. Psychiatry,30,292-296.
11. Eggers, A.E.(2013).An explanation of why schizophrenia begins with excitotoxic damage to the hippocampus.Med. Hypotheses,81,1056-1058.
12. Fishbain, D.A.,Cutler, R.B.,Lewis, J.,Cole, B.,Rosomoff, S.,Rosomoff, H.L.(2004).Do the second-generation "atypical neuroleptics" have analgesic properties? A structured evidence-based review.Pain Med.,5,4.
13. Fumagalli, F.,Molteni, R.,Bedogni, F.,Gennarelli, M.,Perez, J.,Racagni, G.,Riva, M.A.(2004).Quetiapine regulates FGF-2 and BDNF expression in the hippocampus of animals treated with MK-801.Neuroreport,15,2109-2112.
14. Gassó, P.,Mas, S.,Molina, O.,Bernardo, M.,Lafuente, A.,Parellada, E.(2012).Neurotoxic/neuroprotective activity of haloperidol, risperidone and paliperidone in neuroblastoma cells.Prog. Neuro-Psychopharmacol. Biol. Psychiatry,36,71-77.
15. Kantrowitz, J.,Citrome, L.(2008).Paliperidone: the evidence of its therapeutic value in schizophrenia.Core Evid.,2,261-271.
16. Kołaczkowski, M.,Mierzejewski, P.,Bienkowski, P.,Wesołowska, A.,Newman-Tancredi, A.(2014).Antipsychotic, antidepressant, and cognitive-impairment properties of antipsychotics: rat profile and implications for behavioral and psychological symptoms of dementia.Naunyn-Schmiedeberg's Arch. Pharmacol.,387,545-557.
17. Lalonde, R.,Strazielle, C.(2008).Relations between open-field, elevated plus-maze, and emergence tests as displayed by C57/BL6J and BALB/c mice.J. Neurosci. Methods,171,48-52.
18. MacDowell, K.S.,Munarriz-Cuezva, E.,Caso, J.R.,Madrigal, J.L.,Zabala, A.,Meana, J.J.,García-Bueno, B.,Leza, J.C.(2017).Paliperidone reverts toll-like receptor 3 signaling pathway activation and cognitive deficits in a maternal immune activation mouse model of schizophrenia.Neuropharmacology,116,196-207.
19. Martinotti, G.,Di Iorio, G.,Marini, S.,Ricci, V.,De Berardis, D.,Di Giannantonio, M.(2012).Nerve growth factor and brain-derived neurotrophic factor concentrations in schizophrenia: a review.J. Biol. Regul. Homeost. Agents,26,347-356.
20. McLelland, A.E, Martin-Iverson, M.T.,Beninger, R.J.(2014).The effect of quetiapine (Seroquel™) on conditioned place preference and elevated plus maze tests in rats when administered alone and in combination with (+)-amphetamine.Psychopharmacology,231,4349-4359.
21. Minassian, A.,Young, J.W.(2010).Evaluation of the clinical efficacy of asenapine in schizophrenia.Expert Opin. Pharmacol.,11,2107-2115.
22. Mu, J.S.,Li, W.P.,Yao, Z.B.,Zhou, X.F.(1999).Deprivation ofendogenous brain-derived neurotrophic factor results inimpairment of spatial learning and memory in adult rats.Brain Res.,835,259-265.
23. Nagai, T.,Noda, Y.,Une, T.,Furukawa, K.,Furukawa, H.,Kan, Q.M.,Nabeshima, T.(2003).Eject of AD-5423 on animal models of schizophrenia: phencyclidine-induced behavioral changes in mice.Neuroreport,14,2.
24. Pilkinton, P.,Berry, C.,Norrholm, S.,Bartolucci, A.,Birur, B.,Davis, L.L.(2016).An open label pilot study of adjunctive asenapine for the treatment of posttraumatic stress disorder.Psychopharmacol. Bull.,46,8-17.
25. Porsolt, R.D.,Bertin, A.,Jalfre, M.(1977).Behavioral despair in mice: a primary screening test for antidepressants.Arch. Int. Pharmacodyn. Ther.,229,327-336.
26. Rajkumar, R.,Pandey, D.K.,Mahesh, R.,Radha, R.(2009).1-(m-Chlorophenyl)piperazine induces depressogenic-like behavior in rodents by stimulating the neuronal 5-HT receptors: Proposal of a modified rodent antidepressant assay.Eur. J. Pharmacol.,608,32-41.
27. Rogó, Z.,Kabziñski, M.(2011).Enhancement of the antiimmobility action of antidepressants by risperidone in the forced swimming test in mice.Pharmacol. Rep.,63,1533-1538.
28. Rogóż, Z.,Skuza, G.(2011).Anxiolytic-like effects of olanzapine, risperidone and fluoxetine in the elevated plus-maze test in rats.Pharmacol. Rep.,63,1547-1552.
29. Savli, H.,Karadenizli, A.,Kolayli, F.,Gundes, S.,Ozbek, U.,Vahaboglu, H.(2003).Expression stability of six housekeeping genes: a proposal for resistance gene quantification studies of Pseudomonas aeruginosa by real-time quantitative RT-PCR.J. Med. Microbiol.,52,403-408.
30. Schreiber, S.,Backer, M.M.,Weizman, R.,Pick, C.G.(1997).Augmentation of opioid induced antinociception by the atypical antipsychotic drug risperidone in mice.Neurosci. Lett.,228,25-28.
31. Schreiber, S.,Getslev, V.,Backer, M.M.,Weizman, R.,Pick, C.G.(1999).The atypical neuroleptics clozapine and olanzapine differ regarding their antinociceptive mechanisms and potency.Pharmacol. Biochem. Behav.,64,75-80.
32. Schulman, H.(1995).Protein phosphorylation in neuronal plasticity and gene expression.Curr. Opin. Neurobiol.,5,375-381.
33. Tardito, D.,Perez, J.,Tiraboschi, E.,Musazzi, L.,Racagni, G.,Popoli, M.(2006).Signaling pathways regulating gene expression, neuroplasticity, and neurotrophic mechanisms in the action of antidepressants: a critical overview.Pharmacol. Rev.,58,115-134.
34. Taukulis, H.K.,Fillmore, M.T.,Ruggles, J.L.(1992).Neuroleptic-induced changes in the anxiolytic and myorelaxant properties of diazepam in the rat.Pharmacol. Biochem. Behav.,41,13-21.
35. Wang, Y.,Chang, T.,Chen, Y.C.,Zhang, R.G.,Wang, H.N.,Wu, W.J.,Peng, Z.W.,Tan, Q.R.(2011).Quetiapine add-on therapy improves the depressive behaviors and hippocampal neurogenesis in fluoxetine treatment resistant depressive rats.Behav. Brain Res.,253,206-211.
36. Weiner, I.,Schiller, D.,Gaisler-Salomon, I.,Green, A.,Joel, D.(2003).A comparison of drug effects in latent inhibition and the forced swim test differentiates between the typical antipsychotic halo-peridol, the atypical antipsychotics clozapine and olanzapine, and the antidepressants imipramine and paroxetine.Behav. Pharmacol.,14,215-222.
37. Wilner, K.D.,Anziano, R.J.,Johnson, A.C.,Miceli, J.J.,Fricke, J.R.,Titus, C.K.(2002).The anxiolytic effect of the novel antipsychotic ziprasidone compared with diazepam in subjects anxious before dental surgery.J. Clin. Psychopharmacol.,22,206-210.
38. Zhao, Y.J.,Lin, L.,Teng, M.,Khoo, A.L.,Soh, L.B.,Furukawa, T.A.,Baldessarini, R.J.,Lim, B.P.,Sim, K.(2016).Long-term antipsychotic treatment in schizophrenia: systematic review and network meta-analysis of randomised controlled trials.Brit. J. Psych. Open,2,59-66.
39. Zhuravliova, E.,Barbakadze, T.,Natsvlishvili, N.,Mikeladze, D.G.(2007).Haloperidol induces neurotoxicity by the NMDA receptor downstream signalling pathway, alternative from glutamate excitotoxicity.Neurochem. Int.,50,976-982.